D'Andrea David, Soria Francesco, Abufaraj Mohammad, Gust Kilian, Foerster Beat, Vartolomei Mihai D, Kimura Shoji, Mari Andrea, Briganti Alberto, Remzi Mesut, Seitz Christian K, Mathieu Romain, Karakiewicz Pierre I, Shariat Shahrokh F
Department of Urology, Medical University of Vienna, Vienna, Austria.
Department of Urology, Medical University of Vienna, Vienna, Austria; Division of Urology, Department of Special Surgery, Jordan University Hospital, The 2 University of Jordan, Amman, Jordan.
Urol Oncol. 2018 Dec;36(12):528.e7-528.e13. doi: 10.1016/j.urolonc.2018.09.015. Epub 2018 Nov 13.
To evaluate the predictive and prognostic role as well as the clinical impact on decision-making of serum cholinesterase (ChoE) levels in patients treated with radical prostatectomy for clinically nonmetastatic prostate cancer.
We conducted a retrospective analysis of our multi institutional database. Preoperative ChoE was evaluated as continuous and dichotomized variable using a visual assessment of the functional form of the association of ChoE with biochemical recurrence (BCR)-free survival. We assessed its association with perioperative clinicopathologic characteristics and outcomes. Multivariable models established its independent prognostic value for BCR. Cox proportional hazard coefficients were used to build nomograms for the prediction of early and late BCR. Decision curve analysis was used to assess the clinical impact on decision making of preoperative ChoE.
In all, 6,041 patients were available for the analysis. Decreased ChoE was associated with higher biopsy Gleason score, preoperative PSA levels, pathologic Gleason score, pathological stage, lymph node metastasis, positive surgical margin, and lymphovascular invasion at radical prostatectomy (all P < 0.01). Preoperative ChoE ≤ 6.52 U/ml was associated with higher probability of BCR (HR 1.72, 95% CI 1.48-1.99, P < 0.001). Preoperative and postoperative multivariable models that adjusted for the effects of established clinicopathologic features confirmed its independent association with BCR. In decision curve analysis inclusion of preoperative ChoE did not improve the net benefit of preoperative and postoperative models for the prediction of BCR.
Despite independent association with clinicopathologic features and BCR, preoperative serum ChoE has no impact on clinical decision making. Future studies should investigate the possible relationship between ChoE activity and neoplastic cell transformation with a rational for targeting.
评估血清胆碱酯酶(ChoE)水平在接受根治性前列腺切除术治疗的临床非转移性前列腺癌患者中的预测和预后作用以及对决策的临床影响。
我们对多机构数据库进行了回顾性分析。术前ChoE被评估为连续变量和二分变量,通过对ChoE与无生化复发(BCR)生存之间关联的功能形式进行视觉评估。我们评估了其与围手术期临床病理特征和结局的关联。多变量模型确定了其对BCR的独立预后价值。使用Cox比例风险系数构建预测早期和晚期BCR的列线图。决策曲线分析用于评估术前ChoE对决策的临床影响。
总共6041例患者可用于分析。ChoE降低与更高的活检Gleason评分、术前PSA水平、病理Gleason评分、病理分期、淋巴结转移、手术切缘阳性和根治性前列腺切除术中的淋巴管浸润相关(所有P<0.01)。术前ChoE≤6.52 U/ml与BCR的更高概率相关(HR 1.72,95%CI 1.48-1.99,P<0.001)。调整既定临床病理特征影响的术前和术后多变量模型证实了其与BCR的独立关联。在决策曲线分析中,纳入术前ChoE并未改善术前和术后模型预测BCR的净效益。
尽管术前血清ChoE与临床病理特征和BCR独立相关,但对临床决策没有影响。未来的研究应调查ChoE活性与肿瘤细胞转化之间可能的关系,并确定靶向治疗的理论依据。